Search results for “CXCR4 antagonist” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 206 patents, we discovered top 28 key players by total patent application. Genzyme Corp., Eli Lilly & Co., Biokine Therapeutics Ltd. are dominant in this area. They take 44.17% of the total patent filing.
Genzyme Corp.
Massachusetts, United States
Patent: 35
Eli Lilly & Co.
Indiana, United States
Patent: 33
Biokine Therapeutics Ltd.
Israel
Patent: 23
Proximagen LLC
United States
Patent: 17
BioLineRx Ltd.
Israel
Patent: 15
Kura Oncology, Inc.
California, United States
Patent: 8
AnorMED, Inc.
British Columbia, Canada
Patent: 8
Schering Corp.
New Jersey, United States
Patent: 8
Chemokine Therapeutics Corp.
British Columbia, Canada
Patent: 7
Kureha Corp.
Hokkaido, Japan
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 46 patents applied in the last 5 years. We discover 18 most active companies in this area. The fast-growing Proximagen LLC, Kura Oncology, Inc., The Board of Regents of The University of Texas System take 50.00% of patent filing during this period.
Proximagen LLC
United States
Patent: 10
Kura Oncology, Inc.
California, United States
Patent: 8
The Board of Regents of The University of Texas System
Texas, United States
Patent: 5
Genzyme Corp.
Massachusetts, United States
Patent: 3
CohBar, Inc.
California, United States
Patent: 3
REMD Biotherapeutics, Inc.
California, United States
Patent: 3
University of Washington
Washington, United States
Patent: 2
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
BenevolentAI Cambridge Ltd.
United Kingdom
Patent: 2
Emory University
Georgia, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 46 patents in last 5 years, we discover 9 new entrants. Kura Oncology, Inc., The Board of Regents of The University of Texas System, CohBar, Inc. are the most active new entrants in this area.
Kura Oncology, Inc.
California, United States
Patent: 8
The Board of Regents of The University of Texas System
Texas, United States
Patent: 5
CohBar, Inc.
California, United States
Patent: 3
REMD Biotherapeutics, Inc.
California, United States
Patent: 3
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
Ningxia Medical University
Ningxia Huizi Zizhiqu, China
Patent: 1
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 1
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 1
Hangzhou Normal University
Zhejiang Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 118 patents, we discovered top 18 universities and scientific research institutions by total patent application. Emory University, University of British Columbia, University of Washington are dominant in this area. They take 58.47% of the total patent filing.
Emory University
Georgia, United States
Patent: 30
University of British Columbia
British Columbia, Canada
Patent: 21
University of Washington
Washington, United States
Patent: 13
Kyoto University
Kyoto-fu, Japan
Patent: 8
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 5
Tsinghua University
Beijing Shi, China
Patent: 3
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 2
National Tsing-Hua University
Taiwan Province, China
Patent: 2
University of Southern California
California, United States
Patent: 1
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: